Stan Smith insider trades

Open-market stock purchases and sales by Stan Smith, Director at MAIA Biotechnology, Inc, from SEC Form 4 filings since Aug 1, 2022.

Track record: 6% of 51 scored buys are up 5% or more since purchase, averaging -56%.

Recent trades

DateStockTradeValue
Sep 30, 2026MAIA MAIA Biotechnology, IncBought (not open market)—
Jun 30, 2026MAIA MAIA Biotechnology, IncBought (not open market)—
Jun 1, 2026MAIA MAIA Biotechnology, IncBought$100K
Mar 31, 2026MAIA MAIA Biotechnology, IncBought (not open market)—
Dec 31, 2025MAIA MAIA Biotechnology, IncBought (not open market)—
Dec 22, 2025MAIA MAIA Biotechnology, IncBought$77.8K
Dec 5, 2025MAIA MAIA Biotechnology, IncBought$5.5K
Nov 26, 2025MAIA MAIA Biotechnology, IncBought$15.6K
Nov 25, 2025MAIA MAIA Biotechnology, IncBought$14.7K
Nov 24, 2025MAIA MAIA Biotechnology, IncBought$9.9K

Companies traded

  • MAIA MAIA Biotechnology, Inc: 51 buys, last Sep 30, 2026

Get free alerts when Stan Smith files a new trade →